PKP4 is identified as a novel modulator of Kir2.1 potassium currents, providing molecular insights into mechanisms that may underlie Andersen-Tawil syndrome.
May inform ATS1 trafficking mechanisms; hypothesis-generating for Kir2.1-targeted therapies pending validation.
, a trafficking deficient ATS1 mutant, thus uncovering molecular mechanisms whose malfunctions may underlie ATS1 disease. Finally, using patch-clamp analysis, we validate the functional relevance of PKP4, one of our top BioID interactors, to the modulation of Kir2.1-controlled inward rectifier potassium currents. Our results validate the power of our BioID approach in identifying functionally relevant Kir2.1 interactors and underline the value of our Kir2.1 interactome as a repository for numerous novel biological hypotheses on Kir2.1 and Kir2.1-associated diseases.
No takes yet. Share an insight, caveat, or question.
Park et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: